Clinical trial
A Phase II Trial of PS-341 in Patients With Renal Cell Cancer
NCT00025376 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of PS-341 in Patients With Renal Cell Cancer
- Lead sponsor
- University of Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2001
- Completion date
- March 31, 2006
- Enrollment
- 23 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer